27 May 2022

The SII Anti-Doping Monitor – week ending 27 May 2022

Just four athletes from four countries, competing in four sports, were involved in anti-doping proceedings that came to light this week. The major news was that Tandara Caixeta, who plays for Brazil’s volleyball team, has been sanctioned with a four year ban for an anti-doping rule violation (ADRV) involving Ostarine. Caixeta was tested outside of competition on 7 July last year, ahead of the postponed Tokyo 2020 Olympics, however was dramatically pulled from the team ahead of its semi-final against South Korea, after the results of the test became known. She is still listed as a Silver Medalist by the International Olympic Committee (IOC).

Caixeta blames her adverse analytical finding (AAF – or ‘positive test’) on contaminated products, and plans to appeal. ‘Although we have more than enough evidence to show that I was contaminated, I received an unjust, disproportionate conviction preceded by a strange leak of a process that was supposed to be confidential’, she wrote on Instagram (below). ‘Unfortunately, the understanding of the First Chamber of the TJDAD [Brazil’s anti-doping tribunal] is incompatible with the best international jurisprudence. In any case, we will appeal to the Plenary so that justice is, in fact, re-established. I respect, but I do not agree with this decision today. I will fight, as I always have, to prove my innocence.’

The importance of checking medication was once again underlined by a case involving a Canadian University Rugby Union player. Alisha Geier was sanctioned with a six month ban – which has expired – after the Canadian Centre for Ethics in Sport (CCES) accepted that her AAF for stimulant, Cathine, was caused by Buckley’s Complete for cough, cold and flu. Cathine isn’t listed as an ingredient in Buckley’s Complete but Pseudoephedrine is, and Cathine is a metabolite of Pseudoephedrine. 

The CCES sought a two year ban, arguing that the athlete had received education about the dangers of Pseudoephedrine. However the Sports Dispute Resolution Centre of Canada (SDRCC) Panel disagreed. It pointed out that Geier had not returned an AAF for Pseudoephedrine but for Cathine, and her Pseudoephedrine levels were within permitted limits. 

‘Having successfully completed the training provided by the CCES the Athlete was specifically taught that Pseudoephedrine (and again, not Cathine) was banned in competition over a certain threshold and she should double check the dosage of her medication to ensure she stayed below that threshold’, reads the Decision. ‘I cannot find that had the Athlete done all that was expected of her there was a way she would have learned that staying below the permitted threshold of pseudoephedrine could still risk an AAF for Cathine.’

Please continue to send any cases we may have missed or suggestions through to our editor by clicking here. Also, if you’re an athlete, national anti-doping organisation (NADO) or other Results Management Authority and you’d like us to cover a case that you’re involved with, please get in touch! Also – a reminder. The SII Anti-Doping Monitor only features confirmed AAFs (‘positive tests’) or confirmed anti-doping rule violations (ADRVs).

Decisions

Michael Reynolds;

Alisha Geier (Statement & Decision);

Tandara Caixeta (Instagram Statement; provisional suspension Statement; provisional suspension Details);

Lorenzo Sodi

You may also like...

Pin It on Pinterest

Share This